Angiogenesis in epithelian ovarian cancer

被引：137
作者：
Bamberger, ES
Perrett, CW
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Obstet & Gynaecol, London NW3 2PF, England
[2] Univ Haifa, Dept Biol, IL-36006 Tivon, Israel
来源：
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY | 2002年 / 55卷 / 06期
关键词：
D O I：
10.1136/mp.55.6.348
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Angiogenesis, the development of new blood vessels from the existing vasculature, is an essential component of solid tumour growth and metastasis. Several angiogenic factors are expressed by many tumours, suggesting that tumours promote their own vascularisation by activating the host endothelium. This review will discuss various angiogenic stimulators and inhibitors in epithelian ovarian cancer (EOC), including vascular endothelial growth factor and platelet derived endothelial cell growth factor/thymidine phosphorylase, The analysis of tumour vascularisation by microvessel density will also be discussed and the relevance of these markers of angiogenesis in the prognosis of EOC will be assessed.
引用
收藏
页码：348 / 359
页数：12
相关论文
共 183 条
[1]  
AbuJawdeh GM, 1996, LAB INVEST, V74, P1105
[2]   Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma [J].
Abulafia, O ;
Ruiz, JE ;
Holcomb, K ;
Dimaio, TM ;
Lee, YC ;
Sherer, DM .
OBSTETRICS AND GYNECOLOGY, 2000, 95 (04) :548-552
[3]   THE RELATIONSHIP OF ANGIOGENESIS TO BIOLOGICAL-ACTIVITY IN HUMAN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK [J].
ALBO, D ;
GRANICK, MS ;
JHALA, N ;
ATKINSON, B ;
SOLOMON, MP .
ANNALS OF PLASTIC SURGERY, 1994, 32 (06) :588-594
[4]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[5]  
Alvarez AA, 1999, CLIN CANCER RES, V5, P587
[6]   Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia [J].
Bellomo, D ;
Headrick, JP ;
Silins, GU ;
Paterson, CA ;
Thomas, PS ;
Gartside, M ;
Mould, A ;
Cahill, MM ;
Tonks, ID ;
Grimmond, SM ;
Townson, S ;
Wells, C ;
Little, M ;
Cummings, MC ;
Hayward, NK ;
Kay, GF .
CIRCULATION RESEARCH, 2000, 86 (02) :E29-E35
[7]   Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal [J].
Benjamin, LE ;
Keshet, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8761-8766
[8]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[9]   EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS FLT AND KDR IN OVARIAN-CARCINOMA [J].
BOOCOCK, CA ;
CHARNOCKJONES, DS ;
SHARKEY, AM ;
MCLAREN, J ;
BARKER, PJ ;
WRIGHT, KA ;
TWENTYMAN, PR ;
SMITH, SK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (07) :506-516
[10]   MICROVESSEL QUANTITATION AND PROGNOSIS IN INVASIVE BREAST-CARCINOMA [J].
BOSARI, S ;
LEE, AKC ;
DELELLIS, RA ;
WILEY, BD ;
HEATLEY, GJ ;
SILVERMAN, ML .
HUMAN PATHOLOGY, 1992, 23 (07) :755-761
12345678910